New avenue for anti-depressant therapy discovered

Researchers have made a ground-breaking discovery revealing new molecular information on how the brain regulates depression and anxiety. In so doing, they identified a new molecule that alleviates anxiety and depressive behaviour in rodents. The research, led by Eleanor Coffey, Research Director at Åbo Akademi University in Finland is a collaborative effort between scientists in Finland and the US.

The researchers found that a protein called JNK when active, represses the generation of new neurons in the hippocampus, a part of the brain that controls emotions and learning. By inhibiting JNK solely in newly generated nerve cells in the hippocampus, the researchers were able to alleviate anxiety and depressive behaviour in mice. This previously unknown mechanism brings fresh insight on how the brain works to regulate mood and indicates that inhibitors of JNK, such as the one used here, can provide a new avenue for anti-depressant and anxiolytic drug development.

2 Likes

How long do we have to wait for this one ?

Good question… but at least things are moving forward, if only at a snail’s pace :slight_smile:

3 Likes

Maybe they can fast track one of these babies into my pill cabinet. The depression is what gets us

1 Like

I just emailed the lead researcher. Want to see what their time frame looks like. Hopefully they will respond

2 Likes